HealthLynked Corp.
HLYK · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.23 | 0.09 | -1.37 |
| FCF Yield | -58.04% | -20.40% | -26.31% | -3.57% |
| EV / EBITDA | -1.59 | -8.02 | -2.54 | -10.53 |
| Quality | ||||
| ROIC | 219.47% | -149.42% | -339.46% | -53.91% |
| Gross Margin | 96.80% | 41.05% | 92.09% | 67.17% |
| Cash Conversion Ratio | 0.57 | 4.09 | 0.54 | 0.36 |
| Growth | ||||
| Revenue 3-Year CAGR | -19.92% | -14.63% | -1.52% | 31.78% |
| Free Cash Flow Growth | 15.67% | 5.48% | -15.77% | -76.87% |
| Safety | ||||
| Net Debt / EBITDA | -0.21 | -0.63 | -0.17 | 0.23 |
| Interest Coverage | -3.15 | -8.11 | -75.71 | -263.44 |
| Efficiency | ||||
| Inventory Turnover | 2.15 | 25.32 | 2.40 | 22.38 |
| Cash Conversion Cycle | -1,430.99 | 1.27 | -507.35 | -17.28 |